Last reviewed · How we verify

NCT04539704

Assessing Impacts of Static Magnetic Fields on Peripheral Pulses and Skin Blood Flow

Completed NA Last updated 10 June 2025
What this trial tests

NA trial testing magnet and sham in Arterial Stiffness in 12 participants. Completed in 31 December 2024.

Timeline
1 February 2023
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorNova Southeastern University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingdouble
Primary purposebasic science
Enrollment12
Start date1 February 2023
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Nova Southeastern University

Who can join

Adults 18 to 35, any sex, with Arterial Stiffness or Magnetic Field Exposure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to investigate and determine the effects of static magnetic fields produced by a small magnet on peripheral pulses and skin blood flow.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Finger skin blood perfusion during exposure of ulnar and median nerves to the static magnetic field of a rare-earth magnet: A randomized pilot study.
    Mayrovitz HN, Astudillo A, Shams E. · · 2021 · cited 4× · PMID 33283550 · DOI 10.1080/15368378.2020.1856682

Verify or expand the search:

Other recruiting trials for Arterial Stiffness

Currently open trials in the same condition.

Other Nova Southeastern University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04539704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing